Literature DB >> 18256072

Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?

R Vos1, B M Vanaudenaerde, N Geudens, L J Dupont, D E Van Raemdonck, G M Verleden.   

Abstract

Airway colonisation with Pseudomonads, especially Pseudomonas aeruginosa, is common in lung transplant (LTx) recipients. The current authors investigated whether pseudomonal colonisation affects the prevalence of bronchiolitis obliterans syndrome (BOS) after lung transplantation. In the present retrospective study, 92 double (SS)LTx recipients (26 cystic fibrosis (CF) and 66 non-CF patients), with at least two consecutive post-operative bronchoalveolar lavage or sputum cultures evaluated for Pseudomonads, were included. Freedom of BOS was investigated in post-operatively colonised and noncolonised patients. The current study has shown post-operative airway colonisation to be an independent risk factor for BOS stage > or = 1 and to be associated with a worse BOS stage > or = 1-free survival in univariate analysis, especially in CF SSLTx recipients. Multivariate analysis demonstrated a trend for colonisation only as an independent risk factor for BOS; however, this pointed to a possible role in the development of BOS. In conclusion, pseudomonal airway colonisation after lung transplantation may be associated with an increased prevalence of bronchiolitis obliterans syndrome, especially in cystic fibrosis patients. Possible pathophysiological mechanisms in the development of bronchiolitis obliterans syndrome need further investigation, although the induction of neutrophilic airway inflammation seems to be its main characteristic.

Entities:  

Mesh:

Year:  2008        PMID: 18256072     DOI: 10.1183/09031936.00128607

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  47 in total

Review 1.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 2.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 3.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

4.  Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation.

Authors:  Siddhartha G Kapnadak; Gregory A Kicska; Kathleen J Ramos; Desiree A Marshall; Tamara Y Carroll; Sudhakar N Pipavath; Michael S Mulligan; Christopher H Goss; Moira L Aitken
Journal:  J Cyst Fibros       Date:  2017-07-28       Impact factor: 5.482

5.  Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients.

Authors:  Nirmal S Sharma; Keith M Wille; S Athira; Degui Zhi; Kenneth P Hough; Enrique Diaz-Guzman; Kui Zhang; Ranjit Kumar; Sunad Rangarajan; Peter Eipers; Yong Wang; Ritesh K Srivastava; Jose Vicente Rodriguez Dager; Mohammad Athar; Casey Morrow; Charles W Hoopes; David D Chaplin; Victor J Thannickal; Jessy S Deshane
Journal:  J Heart Lung Transplant       Date:  2017-07-15       Impact factor: 10.247

6.  Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality.

Authors:  Hsuanwen C Huang; S Samuel Weigt; Ariss Derhovanessian; Vyacheslav Palchevskiy; Abbas Ardehali; Rajan Saggar; Rajeev Saggar; Bernard Kubak; Aric Gregson; David J Ross; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  J Heart Lung Transplant       Date:  2011-04-08       Impact factor: 10.247

Review 7.  The lung microbiome after lung transplantation.

Authors:  Julia Becker; Valeriy Poroyko; Sangeeta Bhorade
Journal:  Expert Rev Respir Med       Date:  2014-04       Impact factor: 3.772

8.  Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients.

Authors:  J C Young; C Chehoud; K Bittinger; A Bailey; J M Diamond; E Cantu; A R Haas; A Abbas; L Frye; J D Christie; F D Bushman; R G Collman
Journal:  Am J Transplant       Date:  2014-11-17       Impact factor: 8.086

9.  Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Authors:  Aric L Gregson; Xiaoyan Wang; S Sam Weigt; Vyacheslav Palchevskiy; Joseph P Lynch; David J Ross; Bernard M Kubak; Rajan Saggar; Michael C Fishbein; Abbas Ardehali; Gang Li; Robert Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

Review 10.  Impact of multidrug-resistant organisms on patients considered for lung transplantation.

Authors:  Shmuel Shoham; Pali D Shah
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.